Grant Bogle

Track

Insider profile

Currently holds a position at Epizyme Inc

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Epizyme Inc Sept. 2, 2019 -
Senior Vice President, Chief Commercial Officer TESARO Inc July 1, 2015 - Jan. 22, 2019
Grant Bogle's trades of Braemar PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
GB Braemar PLC (BMS)
Transaction date
Purchase
Price
158.32
Quantity 21,118
Value £2,734,721
US TESARO Inc (TSRO)
Transaction date
Planned sale
Price
191.83
Quantity 31,084 -33.9%
Value US$1,497,641
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-22 2024-11-21
GB Braemar PLC (BMS)
B Purchase
21,118
158.32
£2,734,721 		21,118 158.32 £2,734,721
2018-03-05 2018-03-01
US TESARO Inc (TSRO)
PlS Planned sale
31,084 -33.9%
191.83
US$1,497,641 		31,084 -33.9% 191.83 US$1,497,641